Related Experiment Videos
Cirrhotic cardiomyopathy: getting to the heart of the matter
Insights
Cirrhotic cardiomyopathy is characterized by abnormal heart function in cirrhosis patients, showing hyporesponsiveness to stress. This condition, affecting cardiac output, requires careful cardiovascular monitoring in liver disease management.
Area of Science:
- Cardiology
- Hepatology
- Pharmacology
Background:
- Cirrhosis is associated with abnormal cardiac contractile function, presenting as hyperdynamic circulation at baseline.
- Ventricular hyporesponsiveness to stress is a key feature, observed in both human patients and animal models.
- This condition is termed "cirrhotic cardiomyopathy" and can occur independently of alcohol abuse.
Purpose of the Study:
- To review the pathophysiology of cirrhotic cardiomyopathy.
- To discuss the role of various factors in its development.
- To emphasize the importance of cardiovascular monitoring in cirrhotic patients.
Main Methods:
- Review of existing literature on cirrhotic cardiomyopathy.
- Analysis of pathogenic factors including myocardial signaling, membrane properties, and circulatory changes.
- Discussion of clinical implications for cirrhotic patients.
Main Results:
- Diminished myocardial beta-adrenergic receptor signal transduction, linked to elevated norepinephrine, is a significant factor.
- Alterations in cardiac plasma membrane properties due to impaired lipid metabolism are crucial.
- Cardiodepressant substances and ventricular overload secondary to hyperdynamic circulation also contribute.
Conclusions:
- Cirrhotic cardiomyopathy involves complex cardiac dysfunction in liver cirrhosis.
- Understanding the underlying mechanisms is vital for patient management.
- Close cardiovascular monitoring is essential, particularly during stressful procedures like liver transplantation.
Abstract:
In cirrhosis, cardiac contractile function has been extensively documented to be abnormal. At baseline, cardiac output is increased, and this is one of the characteristics of hyperdynamic circulation. However, when cirrhotic patients are challenged by pharmacological or physiological stress, ventricular hyporesponsiveness is revealed. Similar patterns have been noted in cirrhotic animal models. This phenomenon has been termed "cirrhotic cardiomyopathy." Although alcohol abuse may contribute to some cases of cirrhotic cardiomyopathy, it has been clearly documented to occur even in the absence of alcohol ingestion. Diminished myocardial beta-adrenergic receptor signal transduction function, possibly caused by a persistent elevation in norepinephrine content, has been shown to play an important role. Alternation in cardiac plasma membrane properties due to impaired lipid metabolism is also crucial. Other possible pathogenic factors are reviewed, including accumulation of cardiodepressant substances caused by hepatocellular insufficiency, and ventricular overload secondary to increased blood volume and hyperdynamic circulation. Because the cardiac reserve function is borderline in patients with cirrhosis, cardiovascular status should be carefully monitored, especially when patients undergo stresses such as liver transplantation or portosystemic shunting procedures.